查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
進階創傷護理市場：按產品、應用和最終用戶分類：2023-2032 年全球機會分析和產業預測
市場調查報告書
商品編碼
1414715

進階創傷護理市場：按產品、應用和最終用戶分類：2023-2032 年全球機會分析和產業預測

Advanced Wound Care Market By Product, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 278 Pages | 商品交期: 2-3個工作天內

價格

2022年先進創傷護理市場價值為103億美元，預計2023年至2032年複合年成長率為5.6%，到2032年達到178億美元。

先進傷口護理市場-IMG1

該報告可以客製化（需要單獨的費用和時間表）。

  • 監管指引
  • 根據客戶興趣加入公司簡介
  • 按國家或地區進行的附加分析 – 市場規模和預測
  • 公司簡介的擴充列表
  • 歷史市場資料
  • SWOT分析

目錄

第1章簡介

第 2 章執行摘要

第3章市場概況

  • 市場定義和範圍
  • 主要發現
    • 影響因素
    • 主要投資機會
  • 波特五力分析
  • 市場動態
    • 促進因素
      • 糖尿病、肥胖症和慢性病的增加
      • 創傷護理管理的技術進步
      • 增加傷口護理新產品的推出
    • 抑制因素
      • 關於創傷護理產品生產的嚴格規定
    • 機會
      • 擴大新興市場的商機

第4章先進傷口護理市場：依產品

  • 概述
  • 感染控制
    • 按感染控制類型分類的高階創傷護理市場
  • 滲出物管理
    • 滲出物管理高級創傷護理市場：按類型
  • 積極的創傷護理
    • 積極的創傷護理高級創傷護理市場：按類型
  • 治療裝置
    • 按治療設備類型分類的高級創傷護理市場

第5章高階創傷護理市場：依應用分類

  • 概述
  • 慢性傷口
    • 慢性傷口高級創傷護理市場：按類型
  • 急性傷口
    • 按急性傷口類型分類的高級創傷護理市場

第6章 進階創傷護理市場：依最終使用者分類

  • 概述
  • 醫院
  • 居家醫療
  • 其他

第7章高級創傷護理市場：按地區

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 拉丁美洲/中東/非洲
    • 巴西
    • 沙烏地阿拉伯
    • 南非
    • 其他

第8章 競爭形勢

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 2022年主要企業定位

第9章 公司簡介

  • Smith & Nephew plc
  • 3M Company
  • Molnlycke Health Care AB
  • ORGANOGENESIS HOLDINGS INC.
  • B. Braun SE
  • Coloplast
  • Integra LifeSciences Holdings Corporation
  • MIMEDX Group, Inc.
  • Cardinal Health Inc.
  • ConvaTec Group plc
Product Code: A00756

According to a new report published by Allied Market Research, titled, "Advanced Wound Care Market," The advanced wound care market was valued at $10.3 billion in 2022, and is estimated to reach $17.8 billion by 2032, growing at a CAGR of 5.6% from 2023 to 2032.

Advanced Wound Care Market - IMG1

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By End User

  • Hospitals
  • Homecare Settings
  • Others

By Product

  • Infection Management
    • Type
    • Silver Wound Dressings
    • Non-Silver Dressings
    • Collagen Dressings
  • Exudate Management
    • Type
    • Hydrocolloids Dressings
    • Foam Dressings
    • Alginate Dressings
    • Hydrogel Dressings
  • Active Wound Care
    • Type
    • Skin Substitutes
    • Growth Factors
  • Therapy Devices
    • Type
    • Negative Pressure Wound Therapy (NPWT)
    • Oxygen and Hyperbaric Oxygen Equipment
    • Electromagnetic Therapy Devices
    • Others

By Application

  • Acute Wounds
    • Type
    • Burns and Trauma
    • Surgical Wounds
  • Chronic Wounds
    • Type
    • Pressure Ulcers
    • Diabetic Foot Ulcers
    • Venous Leg Ulcers
    • Arterial Ulcers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Smith & Nephew plc
    • 3M Company
    • B. Braun SE
    • Integra LifeSciences Holdings Corporation
    • Cardinal Health Inc.
    • MIMEDX Group, Inc.
    • Molnlycke Health Care AB
    • Coloplast
    • ConvaTec Group plc
    • ORGANOGENESIS HOLDINGS INC.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. High bargaining power of suppliers
    • 3.3.2. Moderate threat of new entrants
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. Moderate intensity of rivalry
    • 3.3.5. High bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase in prevalence of diabetes, obesity, and chronic conditions
      • 3.4.1.2. Technological advancements in wound care management
      • 3.4.1.3. Rise in new product launches for wound care treatment
    • 3.4.2. Restraints
      • 3.4.2.1. Stringent regulations for manufacturing of wound care products
    • 3.4.3. Opportunities
      • 3.4.3.1. Growing opportunity in emerging markets

CHAPTER 4: ADVANCED WOUND CARE MARKET, BY PRODUCT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Infection Management
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
    • 4.2.4. Infection Management Advanced Wound Care Market by Type
  • 4.3. Exudate Management
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
    • 4.3.4. Exudate Management Advanced Wound Care Market by Type
  • 4.4. Active Wound Care
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
    • 4.4.4. Active Wound Care Advanced Wound Care Market by Type
  • 4.5. Therapy Devices
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country
    • 4.5.4. Therapy Devices Advanced Wound Care Market by Type

CHAPTER 5: ADVANCED WOUND CARE MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Chronic Wounds
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
    • 5.2.4. Chronic Wounds Advanced Wound Care Market by Type
  • 5.3. Acute Wounds
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
    • 5.3.4. Acute Wounds Advanced Wound Care Market by Type

CHAPTER 6: ADVANCED WOUND CARE MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Hospitals
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Homecare Settings
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: ADVANCED WOUND CARE MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Product
    • 7.2.3. Market size and forecast, by Application
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Product
      • 7.2.5.1.2. Market size and forecast, by Application
      • 7.2.5.1.3. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Product
      • 7.2.5.2.2. Market size and forecast, by Application
      • 7.2.5.2.3. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Product
      • 7.2.5.3.2. Market size and forecast, by Application
      • 7.2.5.3.3. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Product
    • 7.3.3. Market size and forecast, by Application
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by Product
      • 7.3.5.1.2. Market size and forecast, by Application
      • 7.3.5.1.3. Market size and forecast, by End User
      • 7.3.5.2. France
      • 7.3.5.2.1. Market size and forecast, by Product
      • 7.3.5.2.2. Market size and forecast, by Application
      • 7.3.5.2.3. Market size and forecast, by End User
      • 7.3.5.3. UK
      • 7.3.5.3.1. Market size and forecast, by Product
      • 7.3.5.3.2. Market size and forecast, by Application
      • 7.3.5.3.3. Market size and forecast, by End User
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Market size and forecast, by Product
      • 7.3.5.4.2. Market size and forecast, by Application
      • 7.3.5.4.3. Market size and forecast, by End User
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Market size and forecast, by Product
      • 7.3.5.5.2. Market size and forecast, by Application
      • 7.3.5.5.3. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Market size and forecast, by Product
      • 7.3.5.6.2. Market size and forecast, by Application
      • 7.3.5.6.3. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Product
    • 7.4.3. Market size and forecast, by Application
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Market size and forecast, by Product
      • 7.4.5.1.2. Market size and forecast, by Application
      • 7.4.5.1.3. Market size and forecast, by End User
      • 7.4.5.2. China
      • 7.4.5.2.1. Market size and forecast, by Product
      • 7.4.5.2.2. Market size and forecast, by Application
      • 7.4.5.2.3. Market size and forecast, by End User
      • 7.4.5.3. India
      • 7.4.5.3.1. Market size and forecast, by Product
      • 7.4.5.3.2. Market size and forecast, by Application
      • 7.4.5.3.3. Market size and forecast, by End User
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Market size and forecast, by Product
      • 7.4.5.4.2. Market size and forecast, by Application
      • 7.4.5.4.3. Market size and forecast, by End User
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Market size and forecast, by Product
      • 7.4.5.5.2. Market size and forecast, by Application
      • 7.4.5.5.3. Market size and forecast, by End User
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Market size and forecast, by Product
      • 7.4.5.6.2. Market size and forecast, by Application
      • 7.4.5.6.3. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Product
    • 7.5.3. Market size and forecast, by Application
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Product
      • 7.5.5.1.2. Market size and forecast, by Application
      • 7.5.5.1.3. Market size and forecast, by End User
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Market size and forecast, by Product
      • 7.5.5.2.2. Market size and forecast, by Application
      • 7.5.5.2.3. Market size and forecast, by End User
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Market size and forecast, by Product
      • 7.5.5.3.2. Market size and forecast, by Application
      • 7.5.5.3.3. Market size and forecast, by End User
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Market size and forecast, by Product
      • 7.5.5.4.2. Market size and forecast, by Application
      • 7.5.5.4.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product mapping of top 10 player
  • 8.4. Competitive dashboard
  • 8.5. Competitive heatmap
  • 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

  • 9.1. Smith & Nephew plc
    • 9.1.1. Company overview
    • 9.1.2. Key executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
    • 9.1.7. Key strategic moves and developments
  • 9.2. 3M Company
    • 9.2.1. Company overview
    • 9.2.2. Key executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
    • 9.2.7. Key strategic moves and developments
  • 9.3. Molnlycke Health Care AB
    • 9.3.1. Company overview
    • 9.3.2. Key executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Business performance
    • 9.3.7. Key strategic moves and developments
  • 9.4. ORGANOGENESIS HOLDINGS INC.
    • 9.4.1. Company overview
    • 9.4.2. Key executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
    • 9.4.7. Key strategic moves and developments
  • 9.5. B. Braun SE
    • 9.5.1. Company overview
    • 9.5.2. Key executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Business performance
  • 9.6. Coloplast
    • 9.6.1. Company overview
    • 9.6.2. Key executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Business performance
    • 9.6.7. Key strategic moves and developments
  • 9.7. Integra LifeSciences Holdings Corporation
    • 9.7.1. Company overview
    • 9.7.2. Key executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
    • 9.7.6. Business performance
  • 9.8. MIMEDX Group, Inc.
    • 9.8.1. Company overview
    • 9.8.2. Key executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
    • 9.8.6. Business performance
    • 9.8.7. Key strategic moves and developments
  • 9.9. Cardinal Health Inc.
    • 9.9.1. Company overview
    • 9.9.2. Key executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
    • 9.9.6. Business performance
  • 9.10. ConvaTec Group plc
    • 9.10.1. Company overview
    • 9.10.2. Key executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
    • 9.10.6. Business performance
    • 9.10.7. Key strategic moves and developments

LIST OF TABLES

  • TABLE 01. GLOBAL ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 02. ADVANCED WOUND CARE MARKET FOR INFECTION MANAGEMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. GLOBAL INFECTION MANAGEMENT ADVANCED WOUND CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 04. ADVANCED WOUND CARE MARKET FOR EXUDATE MANAGEMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 05. GLOBAL EXUDATE MANAGEMENT ADVANCED WOUND CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 06. ADVANCED WOUND CARE MARKET FOR ACTIVE WOUND CARE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. GLOBAL ACTIVE WOUND CARE ADVANCED WOUND CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 08. ADVANCED WOUND CARE MARKET FOR THERAPY DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. GLOBAL THERAPY DEVICES ADVANCED WOUND CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 11. ADVANCED WOUND CARE MARKET FOR CHRONIC WOUNDS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL CHRONIC WOUNDS ADVANCED WOUND CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 13. ADVANCED WOUND CARE MARKET FOR ACUTE WOUNDS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL ACUTE WOUNDS ADVANCED WOUND CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 16. ADVANCED WOUND CARE MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. ADVANCED WOUND CARE MARKET FOR HOMECARE SETTINGS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. ADVANCED WOUND CARE MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. ADVANCED WOUND CARE MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. NORTH AMERICA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 21. NORTH AMERICA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 22. NORTH AMERICA ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 23. NORTH AMERICA ADVANCED WOUND CARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 24. U.S. ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 25. U.S. ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 26. U.S. ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 27. CANADA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 28. CANADA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 29. CANADA ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 30. MEXICO ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 31. MEXICO ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 32. MEXICO ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 33. EUROPE ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 34. EUROPE ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 35. EUROPE ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 36. EUROPE ADVANCED WOUND CARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 37. GERMANY ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 38. GERMANY ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 39. GERMANY ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 40. FRANCE ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 41. FRANCE ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 42. FRANCE ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 43. UK ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 44. UK ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 45. UK ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 46. ITALY ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 47. ITALY ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 48. ITALY ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 49. SPAIN ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 50. SPAIN ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 51. SPAIN ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 52. REST OF EUROPE ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 53. REST OF EUROPE ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 54. REST OF EUROPE ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 55. ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 56. ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 57. ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 58. ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 59. JAPAN ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 60. JAPAN ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 61. JAPAN ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 62. CHINA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 63. CHINA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 64. CHINA ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 65. INDIA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 66. INDIA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 67. INDIA ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 68. AUSTRALIA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 69. AUSTRALIA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 70. AUSTRALIA ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 71. SOUTH KOREA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 72. SOUTH KOREA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 73. SOUTH KOREA ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 74. REST OF ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 75. REST OF ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 76. REST OF ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 77. LAMEA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 78. LAMEA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 79. LAMEA ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 80. LAMEA ADVANCED WOUND CARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 81. BRAZIL ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 82. BRAZIL ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 83. BRAZIL ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 84. SAUDI ARABIA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 85. SAUDI ARABIA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 86. SAUDI ARABIA ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 87. SOUTH AFRICA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 88. SOUTH AFRICA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 89. SOUTH AFRICA ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 90. REST OF LAMEA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 91. REST OF LAMEA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 92. REST OF LAMEA ADVANCED WOUND CARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 93. SMITH & NEPHEW PLC: KEY EXECUTIVES
  • TABLE 94. SMITH & NEPHEW PLC: COMPANY SNAPSHOT
  • TABLE 95. SMITH & NEPHEW PLC: PRODUCT SEGMENTS
  • TABLE 96. SMITH & NEPHEW PLC: PRODUCT PORTFOLIO
  • TABLE 97. SMITH & NEPHEW PLC: KEY STRATERGIES
  • TABLE 98. 3M COMPANY: KEY EXECUTIVES
  • TABLE 99. 3M COMPANY: COMPANY SNAPSHOT
  • TABLE 100. 3M COMPANY: PRODUCT SEGMENTS
  • TABLE 101. 3M COMPANY: PRODUCT PORTFOLIO
  • TABLE 102. 3M COMPANY: KEY STRATERGIES
  • TABLE 103. MOLNLYCKE HEALTH CARE AB: KEY EXECUTIVES
  • TABLE 104. MOLNLYCKE HEALTH CARE AB: COMPANY SNAPSHOT
  • TABLE 105. MOLNLYCKE HEALTH CARE AB: PRODUCT SEGMENTS
  • TABLE 106. MOLNLYCKE HEALTH CARE AB: PRODUCT PORTFOLIO
  • TABLE 107. MOLNLYCKE HEALTH CARE AB: KEY STRATERGIES
  • TABLE 108. ORGANOGENESIS HOLDINGS INC.: KEY EXECUTIVES
  • TABLE 109. ORGANOGENESIS HOLDINGS INC.: COMPANY SNAPSHOT
  • TABLE 110. ORGANOGENESIS HOLDINGS INC.: PRODUCT SEGMENTS
  • TABLE 111. ORGANOGENESIS HOLDINGS INC.: PRODUCT PORTFOLIO
  • TABLE 112. ORGANOGENESIS HOLDINGS INC.: KEY STRATERGIES
  • TABLE 113. B. BRAUN SE: KEY EXECUTIVES
  • TABLE 114. B. BRAUN SE: COMPANY SNAPSHOT
  • TABLE 115. B. BRAUN SE: PRODUCT SEGMENTS
  • TABLE 116. B. BRAUN SE: PRODUCT PORTFOLIO
  • TABLE 117. COLOPLAST: KEY EXECUTIVES
  • TABLE 118. COLOPLAST: COMPANY SNAPSHOT
  • TABLE 119. COLOPLAST: PRODUCT SEGMENTS
  • TABLE 120. COLOPLAST: PRODUCT PORTFOLIO
  • TABLE 121. COLOPLAST: KEY STRATERGIES
  • TABLE 122. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: KEY EXECUTIVES
  • TABLE 123. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT
  • TABLE 124. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: PRODUCT SEGMENTS
  • TABLE 125. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 126. MIMEDX GROUP, INC.: KEY EXECUTIVES
  • TABLE 127. MIMEDX GROUP, INC.: COMPANY SNAPSHOT
  • TABLE 128. MIMEDX GROUP, INC.: PRODUCT SEGMENTS
  • TABLE 129. MIMEDX GROUP, INC.: PRODUCT PORTFOLIO
  • TABLE 130. MIMEDX GROUP, INC.: KEY STRATERGIES
  • TABLE 131. CARDINAL HEALTH INC.: KEY EXECUTIVES
  • TABLE 132. CARDINAL HEALTH INC.: COMPANY SNAPSHOT
  • TABLE 133. CARDINAL HEALTH INC.: PRODUCT SEGMENTS
  • TABLE 134. CARDINAL HEALTH INC.: PRODUCT PORTFOLIO
  • TABLE 135. CONVATEC GROUP PLC: KEY EXECUTIVES
  • TABLE 136. CONVATEC GROUP PLC: COMPANY SNAPSHOT
  • TABLE 137. CONVATEC GROUP PLC: PRODUCT SEGMENTS
  • TABLE 138. CONVATEC GROUP PLC: PRODUCT PORTFOLIO
  • TABLE 139. CONVATEC GROUP PLC: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 01. ADVANCED WOUND CARE MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF ADVANCED WOUND CARE MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN ADVANCED WOUND CARE MARKET (2022 TO 2032)
  • FIGURE 04. TOP INVESTMENT POCKETS IN ADVANCED WOUND CARE MARKET (2023-2032)
  • FIGURE 05. HIGH BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 07. MODERATE THREAT OF SUBSTITUTES
  • FIGURE 08. MODERATE INTENSITY OF RIVALRY
  • FIGURE 09. HIGH BARGAINING POWER OF BUYERS
  • FIGURE 10. GLOBAL ADVANCED WOUND CARE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ADVANCED WOUND CARE MARKET FOR INFECTION MANAGEMENT, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF ADVANCED WOUND CARE MARKET FOR EXUDATE MANAGEMENT, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ADVANCED WOUND CARE MARKET FOR ACTIVE WOUND CARE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF ADVANCED WOUND CARE MARKET FOR THERAPY DEVICES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. ADVANCED WOUND CARE MARKET, BY APPLICATION, 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF ADVANCED WOUND CARE MARKET FOR CHRONIC WOUNDS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ADVANCED WOUND CARE MARKET FOR ACUTE WOUNDS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. ADVANCED WOUND CARE MARKET, BY END USER, 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF ADVANCED WOUND CARE MARKET FOR HOSPITALS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF ADVANCED WOUND CARE MARKET FOR HOMECARE SETTINGS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF ADVANCED WOUND CARE MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 23. ADVANCED WOUND CARE MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 24. U.S. ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 25. CANADA ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 26. MEXICO ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. GERMANY ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. FRANCE ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. UK ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. ITALY ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. SPAIN ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. REST OF EUROPE ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. JAPAN ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. CHINA ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. INDIA ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. AUSTRALIA ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. SOUTH KOREA ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. REST OF ASIA-PACIFIC ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. BRAZIL ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. SAUDI ARABIA ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. SOUTH AFRICA ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. REST OF LAMEA ADVANCED WOUND CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 44. COMPETITIVE DASHBOARD
  • FIGURE 45. COMPETITIVE HEATMAP: ADVANCED WOUND CARE MARKET
  • FIGURE 46. TOP PLAYER POSITIONING, 2022
  • FIGURE 47. SMITH & NEPHEW PLC: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 48. SMITH & NEPHEW PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 49. SMITH & NEPHEW PLC: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 50. 3M COMPANY: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 51. 3M COMPANY: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
  • FIGURE 52. 3M COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 53. 3M COMPANY: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 54. MOLNLYCKE HEALTH CARE AB: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 55. MOLNLYCKE HEALTH CARE AB: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 56. MOLNLYCKE HEALTH CARE AB: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 57. ORGANOGENESIS HOLDINGS INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 58. B. BRAUN SE: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 59. B. BRAUN SE: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 60. B. BRAUN SE: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 61. COLOPLAST: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 62. COLOPLAST: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 63. COLOPLAST: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 64. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 65. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 66. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 67. MIMEDX GROUP, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 68. CARDINAL HEALTH INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 69. CARDINAL HEALTH INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 70. CARDINAL HEALTH INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 71. CONVATEC GROUP PLC: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 72. CONVATEC GROUP PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 73. CONVATEC GROUP PLC: REVENUE SHARE BY REGION, 2022 (%)